Innovus Pharma Expands its OTC Drug Pipeline with the Addition of OmepraCarea?? (a Competitor of Prilosec OTC)

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Companya??) (OTCQB
Venture Market: INNV), an emerging commercial-stage pharmaceutical
company that delivers safe, innovative and effective over-the-counter medicine
and consumer care products to improve mena??s and women's health and
respiratory diseases, today announced that it has entered into a supply
relationship with a third party to supply Innovus Pharma with omeprazole
20mg tablets and omeprazole 20mg 24 hour delayed release capsules
indicated for the treatment of frequent heartburn under the approved
abbreviated new drug application ("ANDAa??) No. 207891 from the U.S. Food
and Drug Administration ("FDAa??). Innovus Pharma will launch the drug
under its own trademark OmepraCarea?? 20mg tablets and OmepraCarea?? DR 20mg
24 hour delayed release capsules.

"We continue to execute on our plan to launch new OTC drugs in niche
therapeutic areas where there is a need for national brands to leverage
our success with FlutiCareA and other drugs and devices we have in the
United States. OmepraCare DRa?? is the third ANDA OTC drug that we intend
to commercialize in the U.S. this year,a?? said Dr. Bassam Damaj, Innovus
Pharmaa??s President and Chief Executive Officer. "We believe that the
market opportunity for us with this product is fairly large given the
success of the product PrilosecA OTC and the relatively large size of
the market. Our goal is to launch OmepraCarea?? in the US in the second
half of this year,a?? added Dr. Damaj.

"In addition, it is our current intention to add up to 10 additional
ANDA OTC products to our US drug pipeline,a?? he continued.

About OmepraCare

OmepraCarea?? which is an OTC branded version of omeprazole and a
competitor of PrilosecA OTC, is a proton pump inhibitor to reduce
stomach acidity. It contains the #1 Doctora? recommended
active drug molecule for treatment of frequent heartburn for 10
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«     2020    »